India has a population of 511.4 million women aged 15 years and older who are at risk of developing cervical cancer. Cervical cancer ranks as the second most frequent cancer among women in India.
As per data from the HPV Information Centre, India faces a considerable risk of cervical cancer, with a population of 511.4 million women aged 15 years and older who are potentially susceptible to the disease
Undeniable Death Cases After Gardasil Vaccination theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.
Union Minister of State (Independent Charge) Science & Technology Jitendra Singh on September 01 launched India’s first vaccine against Cervical Cancer at IIC Delhi. The vaccine, Quadrivalent Human Papillomavirus vaccine (qHPV) is developed by the Serum Institute of India (SII) and the Department of Biotechnology(DBT). DCGI had earlier granted market authorisation to Serum Institute of India (SII) to manufacture the indigenously-developed vaccine. Watch video on Zee News